The IPO Buzz: Parabilis Therapeutics (PBLS Proposed) Upsizes IPO by 1/3 to $600 Million
Parabilis Therapeutics (PBLS Proposed) upsized its IPO to 33.33 million shares – up from 25 million initially – and keeping the price range at $17.00 to $19.00 – to raise $600 million, if priced at the $18.00 mid-point of its range, according to an S-1/A filing early today – Tuesday, June 9, 2026. The cancer […]
June 9, 2026 Read More